Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding?

Eur Heart J. 2015 May 21;36(20):1207-11. doi: 10.1093/eurheartj/ehv103. Epub 2015 Apr 2.

Authors

Ronald K Binder¹, Thomas F Lüscher²

Affiliations

¹ Editorial Office, European Heart Journal, Zurich Heart House, Careum Campus, Moussonstreet 4, Zurich 8091, Switzerland.
² Editorial Office, European Heart Journal, Zurich Heart House, Careum Campus, Moussonstreet 4, Zurich 8091, Switzerland thomas.luescher@usz.ch.

PMID: 25838437
DOI: 10.1093/eurheartj/ehv103

No abstract available

Publication types

Editorial

MeSH terms

Acute Coronary Syndrome / therapy
Coronary Artery Disease / therapy*
Drug Therapy, Combination
Drug-Eluting Stents*
Graft Occlusion, Vascular / prevention & control
Hemorrhage / chemically induced*
Humans
Platelet Aggregation Inhibitors / adverse effects*
Prosthesis Failure
Risk Factors
Thrombosis / prevention & control*

Substances

Platelet Aggregation Inhibitors